85 related articles for article (PubMed ID: 9555166)
1. [The role of vaginal smears in the follow-up od menopausal symptoms].
Szántó F
Orv Hetil; 1998 Mar; 139(12):693-5. PubMed ID: 9555166
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of combined oral hormone replacement therapy in postmenopausal symptoms].
Szántó F; Hörömpöli C
Orv Hetil; 1996 May; 137(20):1079-81. PubMed ID: 8657419
[TBL] [Abstract][Full Text] [Related]
3. [Risks and benefits of postmenopausal hormone replacement therapy].
Szántó F
Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
5. Treatment of climacteric complaints with oestriol.
Perović D; Kopajtic B; Stanković T
Arzneimittelforschung; 1975 Jun; 25(6):962-4. PubMed ID: 1100057
[TBL] [Abstract][Full Text] [Related]
6. [Combination of hormone replacement therapy with buspirone in the treatment of climacteric complaints].
Szántó F
Orv Hetil; 2000 Apr; 141(16):835-7. PubMed ID: 10817010
[TBL] [Abstract][Full Text] [Related]
7. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
Pietrzak B; Wielgos M; Kaminski P; Bobrowska K
Neuro Endocrinol Lett; 2006 Jun; 27(3):387-91. PubMed ID: 16816826
[TBL] [Abstract][Full Text] [Related]
8. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
Chandeying V; Sangthawan M
J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
[TBL] [Abstract][Full Text] [Related]
9. Vaginal microflora in postmenopausal women on hormone replacement therapy.
Gupta S; Kumar N; Singhal N; Kaur R; Manektala U
Indian J Pathol Microbiol; 2006 Jul; 49(3):457-61. PubMed ID: 17001923
[TBL] [Abstract][Full Text] [Related]
10. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy.
Gupta S; Kumar N; Singhal N; Manektala U; Jain S; Sodhani P
Diagn Cytopathol; 2006 Oct; 34(10):676-81. PubMed ID: 16955474
[TBL] [Abstract][Full Text] [Related]
11. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
Belaisch J; Nappi C; Affinito P; De Gezelle H; Botelho M; Oliveira HM; Martinez-Oliveira J; Gonzaga F
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
[TBL] [Abstract][Full Text] [Related]
12. [Low-dose estrogens in the treatment of the climacteric syndrome].
Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
15. [Successful hormonal therapy of climacteric disorders].
Täger F
Fortschr Med; 1980 Jul; 98(26-27):1036-8. PubMed ID: 7429389
[TBL] [Abstract][Full Text] [Related]
16. [The influence of the hormonal replacement therapy on conjunctival epithelium morphology among peri- and postmenopausal women].
Okoń A; Jurowski P; Goś R
Klin Oczna; 2001; 103(4-6):183-6. PubMed ID: 11975014
[TBL] [Abstract][Full Text] [Related]
17. Mydocalm treatment of muscular and vascular complaints accompanying climacterics.
Sásdi A
Ther Hung; 1992; 40(2):83-5. PubMed ID: 1462282
[TBL] [Abstract][Full Text] [Related]
18. Benefit and safety of 28-day transdermal estrogen regimen during vaginal hysterectomy (a controlled trial).
Vesna A; Neli B
Maturitas; 2006 Feb; 53(3):282-98. PubMed ID: 16011883
[TBL] [Abstract][Full Text] [Related]
19. Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal women.
Davies GC; Huster WJ; Shen W; Mitlak B; Plouffe L; Shah A; Cohen FJ
Menopause; 1999; 6(3):188-95. PubMed ID: 10486787
[TBL] [Abstract][Full Text] [Related]
20. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
